NCT07389889Not yet recruiting
Percutaneous Robotic Navigation Microwave Ablation Versus CT-guided Microwave Ablation in the Treatment of Pulmonary Nodules With Ground-glass Opacity
Percutaneous Robotic Navigation Microwave Ablation Versus CT-guided Microwave Ablation in the Treatment of Pulmonary Nodules With Ground-glass Opacity: A Prospective Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 5 Feb 2026
Brief summary (registry, in English)
1. To compare the precision of robot-guided microwave ablation and CT-guided microwave ablation in the treatment of ground-glass nodules. 2. To evaluate the safety of robot-assisted microwave ablation and CT-guided microwave ablation in the treatment of ground-glass nodules. 3. Explore the application potential of robot navigation microwave ablation technology in the treatment of pulmonary nodules.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 116 (estimated)
- First submitted
- 10 Dec 2025
- Start date
- Feb 2026
- Primary completion date
- Feb 2028
- Lead sponsor
- Fujian Medical University Union Hospital
- NCT number
- NCT07389889
What you commit to
- Study type: Interventional
- Planned participants: 116
- From Feb 2026 to the primary completion date, Feb 2028
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Continuous systemic corticosteroid therapy within 1 month
Other illness
- Severe mental disorders
- History of other malignancies within 5 years
- Unstable angina or myocardial infarction within 6 months with coronary angiography showing severe stenosis of major coronary branches
- Cerebral infarction or hemorrhage within 6 months
Other
- Smoking cessation duration \<2 weeks
- Lesions adjacent to pulmonary artery-vein main trunks
- Lesions near the hilum or adjacent to lobar bronchi
- Pregnancy or lactation status
- Patients or their authorized persons who do not wish to comply with the study protocol
- Patients with other investigator-assessed ineligibility for the trial
Who the study is looking for
- Aged 18 to 85 years
- Nodules measuring 3-30mm with ground-glass opacities constituting ≥75% of the lesion
- Preoperative clinical evaluation confirming no hilar or mediastinal lymph node metastasis and no distant metastasis
- Patients diagnosed as stage IA primary peripheral lung cancer according to the UICC 8th TNM staging system, and with one of the following conditions:
- (i) cannot undergo surgical resection due to poor cardiopulmonary function or advanced age (ii) refusing or unwilling to undergo surgical resection (iii) with newly developed or residual pulmonary nodules after early-stage primary lung cancer surgery (iv) with unilateral lung disease who cannot undergo unilateral surgical resection (v)with multiple primary lung cancers unsuitable for surgical resection
- Preoperative ECOG physical status score is 0/1
- ASA score is I-III
- Patients voluntarily participate in this study and sign the informed consent form
Age in the registry: 18 years to 85 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.